Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
The metabolome identity: basis for discovery of biomarkers in neurodegeneration
Julie-Myrtille Bourgognon1, Joern R Steinert1
1MRC Toxicology Unit, University of Leicester, Lancaster Road, Leicester, UK.
Abstract:
Neurodegenerative disorders are often associated with cellular dysfunction caused by underlying protein-misfolding signalling. Numerous neuropathologies are diagnosed at late stage symptomatic changes which occur in response to these molecular malfunctions and treatment is often too late or restricted only to the slowing of further cell death. Important new strategies to identify early biomarkers with predictive value to intervene with disease progression at stages where cell dysfunction has not progressed irreversibly is of paramount importance. Thus, the identification of these markers presents an essential opportunity to identify and target disease pathways. This review highlights some important metabolic alterations detected in neurodegeneration caused by misfolded prion protein and discusses common toxicity pathways identified across different neurodegenerative diseases. Thus, having established some commonalities between various degenerative conditions, detectable metabolic changes may be of extreme value as an early diagnostic biomarker in disease.
Insights
Identifying metabolic alterations in neurodegenerative diseases, like those caused by misfolded prion protein, can lead to early diagnostic biomarkers. This approach enables timely intervention before irreversible cell dysfunction occurs.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Neurodegenerative disorders stem from cellular dysfunction linked to protein-misfolding signaling.
- Current diagnostics often detect neuropathologies at late, symptomatic stages, limiting treatment efficacy.
- Early intervention is crucial to halt disease progression before irreversible cell damage.
Purpose of the Study:
- To review metabolic alterations in neurodegeneration associated with misfolded prion protein.
- To discuss common toxicity pathways across various neurodegenerative diseases.
- To highlight the potential of metabolic changes as early diagnostic biomarkers.
Main Methods:
- Literature review focusing on metabolic alterations in prion protein-induced neurodegeneration.
- Analysis of common toxicity pathways in different neurodegenerative conditions.
- Synthesis of findings to identify potential early diagnostic markers.
Main Results:
- Specific metabolic alterations are associated with neurodegeneration caused by misfolded prion protein.
- Shared toxicity pathways exist across diverse neurodegenerative diseases.
- Metabolic changes show promise as early indicators of neurodegenerative disease.
Conclusions:
- Metabolic alterations are key indicators in neurodegenerative diseases.
- Identifying common pathways aids in understanding disease mechanisms.
- Metabolic biomarkers offer a critical opportunity for early diagnosis and intervention in neurodegeneration.
More Related Videos
Related Concept Videos
Personal Identity
Trigonometric Identities II
Social Identity
Trigonometric Identities I
Marcia's Theory of Identity Status
Role-Based Identity

